Back to top
more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$598.03 USD

598.03
2,116,977

-17.66 (-2.87%)

Updated Aug 5, 2024 04:00 PM ET

After-Market: $598.05 +0.02 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (99 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Sheraz Mian headshot

Top Stock Reports for Facebook, Thermo Fisher & McDonalds

Today's Research Daily features new research reports on 16 major stocks, including Facebook (FB), Thermo Fisher Scientific (TMO) and McDonalds (MCD).

Thermo Fisher Grows on Coronavirus Diagnostic Tests Amid Crisis

Thermo Fisher (TMO) is optimistic about ramped up production for its COVID-19 diagnostic test to meet growing global demand.

The Zacks Analyst Blog Highlights: Procter & Gamble, Eli Lilly, Thermo Fisher Scientific, Costco Wholesale and Shopify

The Zacks Analyst Blog Highlights: Procter & Gamble, Eli Lilly, Thermo Fisher Scientific, Costco Wholesale and Shopify

Sreoshi Bera headshot

5 Stocks to Tap the Nanotechnology Market Boom

Given the current scenario, researchers are focusing on nanotechnology as it may offer valuable solutions for COVID-19.

Sheraz Mian headshot

Top Analyst Reports for Procter & Gamble, Eli Lilly & Thermo Fisher

Today's Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG), Eli Lilly (LLY) and Thermo Fisher Scientific (TMO).

Danaher's (DHR) Product Offerings to Aid Amid Pandemic Scares

Danaher's (DHR) risks from pandemic-related uncertainties are evident from weak sales projections for the second quarter. Demand for acute care diagnostics' related products might aid results.

Here's Why You Should Add QIAGEN (QGEN) to Your Portfolio

Investors continue to be optimistic about QIAGEN (QGEN) on robust segmental and geographical growth.

Thermo Fisher (TMO) Partners With CSL to Expand Pharma Arm

Thermo Fisher (TMO), through its alliance with CSL, expands Pharma Services arm to meet the rising demand for biologic therapies.

Why Is Thermo Fisher (TMO) Up 4.8% Since Last Earnings Report?

Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The Zacks Analyst Blog Highlights: SAP, Thermo Fisher, TOTAL, 3M and FIS

The Zacks Analyst Blog Highlights: SAP, Thermo Fisher, TOTAL, 3M and FIS

Mark Vickery headshot

Top Stock Analyst Reports for SAP, Thermo Fisher & TOTAL

Today's Research Daily features new research reports on 16 major stocks, including SAP SE (SAP), Thermo Fisher Scientific (TMO) and TOTAL (TOT).

Thermo Fisher (TMO) Q1 Earnings Top, Life Sciences Sales Grow

On coronavirus-led global supply chain disruption, Thermo Fisher (TMO) records a decline in its quarterly Analytical Instruments revenues.

Thermo Fisher Scientific (TMO) Q1 Earnings and Revenues Surpass Estimates

Thermo Fisher (TMO) delivered earnings and revenue surprises of 5.38% and 0.38%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Sweta Killa headshot

Coronavirus Makes Biotech ETFs Red Hot

The biotech space of the broader healthcare sector is currently the hottest of all segments buoyed by the COVID-19 pandemic.

Will Coronavirus Test Aid Thermo Fisher's (TMO) Q1 Earnings?

Thermo Fisher (TMO) successfully attains EUA from the FDA as well as receives the CE Mark in Europe for its COVID-19 diagnostic test.

Analysts Estimate Thermo Fisher Scientific (TMO) to Report a Decline in Earnings: What to Look Out for

Thermo Fisher (TMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Amazon (AMZN) to Boost Worker Safety With Testing Lab Facility

Amazon (AMZN) to build coronavirus testing lab to ensure safety of its workers.

Here's Why You Should Hold on to Thermo Fisher (TMO) for Now

Investors continue to be optimistic about Thermo Fisher (TMO) on its strong segmental growth in the fourth quarter of 2019.

Sanghamitra Saha headshot

These Medical ETFs & Stocks Deserve a Salute on Health Day

The World Health Day of 2020 puts these medical companies and the related stocks and ETFs in focus.

Amazon (AMZN) in Talks With Test Makers to Screen Workers

Amazon (AMZN) is in contact with Abbott Laboratories and Thermo Fisher Scientific to introduce coronavirus testing at its warehouses.

Sweta Jaiswal, FRM headshot

Healthcare Stocks & ETFs to Gain on Coronavirus Test Progress

It seems that testing for COVID-19 is the major key in controlling the outbreak and helps in making decisions like treatment protocols, resource allocation and drafting the right healthcare policies.

Coronavirus Hits S&P 500: 4 MedTech Stocks That Fared Better

Here are a few MedTech companies which have outperformed the S&P 500 index in the past two months.

Trina Mukherjee headshot

Can Economic Stimulus Save MedTech From Coronavirus Doldrums?

Following the announcement of the agreement to pass the historic stimulus bill, we look into four MedTech stocks that stand to gain from the same.

Sweta Jaiswal, FRM headshot

Healthcare ETFs Gain on Rising Demand for COVID-19 Tests

A growing demand for COVID-19 tests has indulged major healthcare place in the race to develop competent testing kits.

Urmimala Biswas headshot

4 Stocks Countering Coronavirus Battle With Testing Kits

While the market bloodbath is showing no signs of dissipating any time soon, investors might keep an eye on certain genetic testing and medical device companies.